D-0655-2020 Class I Terminated

Recalled by Motto International Corp — Dallas, TX

Recall Details

Product Type
Drugs
Report Date
January 22, 2020
Initiation Date
December 17, 2019
Termination Date
October 29, 2021
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
7 boxes

Product Description

Stallion Platinum 30000 Capsules in blue,orange,white background with red,white text in hologram paper packaging, packaged in 2, 4, 10 count blister cards, Motto International, Dallas, TX

Reason for Recall

Marketed without an Approved NDA/ANDA; FDA analysis found product to contain tadalfil

Distribution Pattern

TX

Code Information

All lots remaining within expiry.